GENZYME GLYCOBIOLOGY RES INST has a total of 29 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, Australia and Taiwan. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are BIOSOURCE GENETICS CORP, ABZYMO BIOSCIENCES CO LTD and CELLSCRIPT LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | Australia | 5 | |
#3 | Taiwan | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Enzymes | |
#4 | Fermentation | |
#5 | Therapeutic chemical compounds | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Canfield William M | 25 |
#2 | Kudo Mariko | 5 |
#3 | Kornfeld Stuart | 4 |
#4 | Canfield William | 3 |
#5 | Kudo Mariko Dr | 1 |
Publication | Filing date | Title |
---|---|---|
WO03057828A2 | Method of producing glycoproteins having reduced complex carbohydrates in mammalian cells | |
AU2002367286A1 | Highly phosphorylated acid beta-glucocerebrosidase and methods of treating gaucher's disease | |
WO03057710A2 | Methods of producing high mannose glycoproteins in complex carbohydrate deficient cells | |
US2003119088A1 | Soluble GlcNAc phosphotransferase | |
US2003143669A1 | Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase | |
US6770468B1 | Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway | |
US6537785B1 | Methods of treating lysosomal storage diseases |